Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
695.00    0.00 (0.00%)
Bid:
690.00
Ask:
700.00
Spread: 10.00 (1.449%)
Market Cap: £244.91m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Hyperion Equity Placement

27 Feb 2006 09:10

B.P. Marsh & Partners PLC27 February 2006 Date: 27 February 2006 On behalf of: B.P. Marsh & Partners Plc ("BP Marsh", "The Marsh Group" or "the Company") For immediate release B.P. Marsh & Partners Plc First Transaction Following AIM Flotation - Investee Company Raises £5.1m B.P. Marsh & Partners Plc, a niche venture capital provider to early stagefinancial services businesses (AIM: BPM), today announces its first transactionfollowing the Company's flotation on AIM on 2 February 2006. Hyperion Insurance Group Limited ("Hyperion"), one of BP Marsh's investeecompanies, has successfully completed an equity placing which raised £5.1million of new capital to fund its ongoing growth plan. In the AdmissionDocument issued by BP Marsh on 2 February 2006, the fair market value of BPMarsh's holding in Hyperion, as at 31 July 2005, is shown as £8,080,440. BP Marsh, which exercised its pre-emption rights, participated in the placing byway of the capitalisation of part of a loan (£1,429,661) which was due to berepaid by Hyperion and maintains its shareholding in Hyperion at 27.9%. MurofoInvestments SLU, a Spanish Investment Company, becomes a new shareholder inHyperion taking a 14% stake. In addition, Luis Munoz-Rojas, director of Murofo,joins the Hyperion Board. Hyperion is one of the UK's fastest growing independent insurance groups andyesterday announced the doubling of its profits by 94% to £4.03 million.Hyperion intends to continue its record of organic growth through establishingstart up operations in new territories as well as actively seeking suitablebusiness operations to add to its group. Hyperion believes this additionalequity will provide sufficient finance for the group's immediate plans. The Marsh Group first invested in Hyperion Insurance Group in 1994. TheHyperion Insurance Group owns, amongst other things, Howden, a registeredLloyd's insurance broker specialising in business critical risks includingdirectors' and officers' ("D&O") and professional indemnity ("PI") insurance.In 1998, Hyperion set up Dual International, an insurance managing generalagency specialising in developing D&O and PI business in Europe. In 2000,Hyperion established CFC Underwriting, a niche underwriting agency specialisingin cyber-liability and technology risks. Commenting on the investment, Chairman Brian Marsh OBE, said: "Over the last three years, Hyperion's revenues have trebled and profits havegrown by a compound annual rate of 42%, making Hyperion one of the fastestgrowing independent insurance groups in the UK. BP Marsh has been a shareholderin Hyperion for more than a decade and we are delighted to be able to continueto support the Group's development." David Howden, Chief Executive of Hyperion Group, comments: "Insurance is playing an increasingly critical role in helping businessesprotect their balance sheets as they face a greater range of risks. We seetremendous opportunities for companies such as ours with the expertise andagility to move quickly into new products and territories in order to respond tothese ever changing needs." For further information: B.P. Marsh & Partners Plc www.bpmarsh.co.uk Brian Marsh, O.B.E. +44 (0)20 7730 2626 Redleaf Communications (PR to BP Marsh)Emma Kane +44 (0)20 7955 1410Rob Bain +44 (0)20 7955 1410 Spotlight (PR to Hyperion)Sarah-Jayne Douglas +44 (0)1252 352399Lesley Russell Notes to Editors: Additional information about BP Marsh and its management: BP Marsh's current portfolio contains nine companies. More detailed descriptionsof the portfolio can be found at www.bpmarsh.co.uk. Over the past 16 years, the Company has assembled a management team withconsiderable experience both in the financial services sector and in managingprivate equity investments. Many of the directors have worked with each other inprevious roles, and all have worked with each other for at least three and ahalf years. Prior to Brian Marsh's involvement in the Company, he spent many years ininsurance broking and underwriting in Lloyd's as well as the London and overseasmarket. He has over 30 years' experience in building, buying and sellingfinancial services businesses, particularly in the insurance sector. Managing Director, Natasha Dunbar, has over 10 years' experience in thefinancial services industry. Having joined the Company in 1994 she was mademanaging director in March 2002. Natasha is responsible for the day to dayrunning of all operational aspects of the business and works closely with BrianMarsh in defining the strategic development of the Company. Investment Director Stephen Crowther joined the Company in 1998. He has over 27years' experience in the London insurance market, in both broking andunderwriting. He researches potential investments, advises investee businessesand monitors their progress. Francis de Zulueta is the Company's Development Director. With a wide-rangingknowledge of the financial services market, he seeks out, researches andevaluates potential new investments for BP Marsh. Following a 23-year brokingcareer with Willis Faber and Aon, among others, he took an active interest inthe mergers, acquisitions and venture capital business of Marsh McLennan. About Hyperion: Established in 1994 and headquartered in the City of London, the HyperionInsurance Group was ranked as one of the UK's fastest growing independentcompanies in the 2005 Sunday Times Profit Track 100 and 15th in the PostMagazine 2005 Top 20 City Brokers report. The Group comprises 21 operations in 11countries employing over 300 people, andoperating through four distinct platforms - wholesale and retail broking,underwriting and reinsurance. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jun 20212:00 pmRNSShare Incentive Plan
8th Jun 20212:41 pmRNSDirector/PDMR Shareholding
8th Jun 20217:00 amRNSFinal Results
12th Apr 20214:07 pmRNSHolding(s) in Company
12th Apr 20214:06 pmRNSHolding(s) in Company
12th Apr 20214:05 pmRNSDirector/PDMR Shareholding
9th Apr 20215:26 pmRNSDirector/PDMR Shareholding
31st Mar 20213:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSInvestee Company Update
4th Mar 20215:50 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSB.P. Marsh Trading Update
29th Jan 20215:11 pmRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSInvestee Company Update: ATC Insurance Solutions
11th Jan 20217:00 amRNSInvestee Company Update - Nexus Underwriting
6th Jan 20215:39 pmRNSDirector/PDMR Shareholding
6th Jan 202112:04 pmRNSInvestee Company Update - XPT Group LLC
22nd Dec 20203:27 pmRNSDirector/PDMR Shareholding
14th Dec 20207:00 amRNSInvestee Company Update – Nexus Underwriting
19th Nov 20207:00 amRNSInvestee Company Update – Lilley Plummer Risks
27th Oct 202010:37 amRNSDirector/PDMR Shareholding
14th Oct 20203:54 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSInterim Results
23rd Sep 20203:01 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSTrading Update
4th Sep 20209:42 amRNSInvestee Company Update: LEBC
25th Aug 202010:36 amRNSInvestee Company Update
14th Aug 202011:41 amRNSDirector/PDMR Shareholding
13th Aug 202010:56 amRNSHolding(s) in Company
12th Aug 20204:14 pmRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSFurther Progress at US Investee Company XPT Group
27th Jul 20204:13 pmRNSDirector/PDMR Shareholding
20th Jul 20205:05 pmRNSResult of AGM
13th Jul 20209:16 amRNSDubai International Financial Centre – EC3 Brokers
30th Jun 20203:21 pmRNSDirector/PDMR Shareholding
29th Jun 20207:00 amRNSInvestment – SAGE Program Underwriters
26th Jun 20203:04 pmRNSNotice of AGM
26th Jun 20209:28 amRNSDirector/PDMR Shareholding
23rd Jun 202012:27 pmRNSTotal Voting Rights
10th Jun 20202:05 pmRNSSecond Price Monitoring Extn
10th Jun 20202:00 pmRNSPrice Monitoring Extension
10th Jun 202011:36 amRNSDirector/PDMR Shareholding
9th Jun 20207:00 amRNSFinal Results
30th Apr 202012:41 pmRNSPortfolio Update
23rd Apr 202010:50 amRNSTotal Voting Rights
23rd Apr 20209:22 amRNSInvestee Company Acquisition
30th Mar 20205:52 pmRNSDirector/PDMR Shareholding
24th Mar 20204:05 pmRNSDirector/PDMR Shareholding
20th Mar 202010:47 amRNSDirector/PDMR Shareholding
13th Mar 20201:52 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSInvestee Company Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.